Stock data
Artelo Biosciences, Inc. (ARTL)
Artelo Biosciences, Inc. (ARTL) reported net income of -US$12.88M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$11.40M | -US$12.88M | — |
| 2024 | — | — | -US$10.11M | -US$9.83M | — |
| 2023 | — | — | -US$9.93M | -US$9.29M | — |
| 2022 | — | — | -US$10.29M | -US$10.08M | — |
| 2021 | — | — | -US$9.42M | -US$9.41M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$2.43M | — |
| 2026-03-31 | — | -US$2.96M | — |
| 2025-12-31 | — | -US$4.17M | — |
| 2025-09-30 | — | -US$3.12M | — |
| 2025-06-30 | — | -US$3.22M | — |
| 2025-03-31 | — | -US$2.37M | — |
| 2024-12-31 | — | -US$3.78M | — |
| 2024-09-30 | — | -US$1.13M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.